Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
B-M Nyhäll-Wåhlin, C Turesson, LTH Jacobsson, J-Å Nilsson, K Forslind, K Albertsson, J Rönnelid & IF Petersson. (2011) The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years. Scandinavian Journal of Rheumatology 40:2, pages 81-87.
Read now
Read now
M Tamai, A Kawakami, N Iwamoto, K Arima, K Aoyagi & K Eguchi. (2010) Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism. Scandinavian Journal of Rheumatology 39:4, pages 287-291.
Read now
Read now
Y Valle, IY Ledezma-Lozano, N Torres-Carrillo, JR Padilla-Gutiérrez, RE Navarro-Hernández, M Vázquez-Del Mercado, CA Palafox-Sánchez, J Armendáriz-Borunda & JF Muñoz-Valle. (2009) Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis. Scandinavian Journal of Rheumatology 38:5, pages 332-335.
Read now
Read now
Articles from other publishers (23)
Peng Cui, Jingwen Wei & Subash C. B. Gopinath. (2023) Carbon nanofiber nanomaterial modified polystyrene enzyme linked immunosorbent assay substrate for detecting osteoporosis. Materials Express 13:5, pages 910-915.
Crossref
Crossref
Rim Sghiri, Hana Benhassine, Khadija Baccouche, Meriem Ghozzi, Sarra Jriri, Zahid Shakoor, Adel Almogren, Foued Slama, Nadia Idriss, Zeineb Benlamine, Elyes Bouajina & Ramzi Zemni. (2022) A CD40 variant is associated with systemic bone loss among patients with rheumatoid arthritis. Clinical Rheumatology 41:6, pages 1851-1858.
Crossref
Crossref
Yuji Kishimoto, Yoshihiro Kato, Manami Uemura & Koji Kuranobu. (2022) Incidence and predictors of fragility fracture in postmenopausal rheumatoid arthritis patients receiving oral bisphosphonates: a longitudinal observational study. BMC Rheumatology 6:1.
Crossref
Crossref
Emma J. Keller, Neeva B. Patel & Trine N. Jorgensen. 2022. Translational Autoimmunity. Translational Autoimmunity
177
198
.
Ming-Han Chen, Shan-Fu Yu, Jia-Feng Chen, Wei-Sheng Chen, The-Ling Liou, Chung-Tei Chou, Chung-Yuan Hsu, Han-Ming Lai, Ying-Chou Chen, Chang-Youh Tsai & Tien-Tsai Cheng. (2021) Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort Study. Frontiers in Immunology 12.
Crossref
Crossref
Ichiro Yoshii, Tatsumi Chijiwa & Naoya Sawada. (2020) Rheumatoid arthritis in tight disease control is no longer risk of bone mineral density loss. Osteoporosis and Sarcopenia 6:2, pages 75-81.
Crossref
Crossref
Julien Grosse, Edem Allado, Camille Roux, Audrey Pierreisnard, Marion Couderc, Isabelle Clerc-Urmes, Thomas Remen, Éliane Albuisson, Marcelo De Carvalho-Bittencourt, Isabelle Chary-Valckenaere & Damien Loeuille. (2019) ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography. Rheumatology International 40:4, pages 615-624.
Crossref
Crossref
T. Tomizawa, H. Ito, K. Murata, M. Hashimoto, M. Tanaka, K. Murakami, K. Nishitani, M. Azukizawa, A. Okahata, K. Doi, M. Saito, M. Furu, M. Hamaguchi, T. Mimori & S. Matsuda. (2019) Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis. Arthritis Research & Therapy 21:1.
Crossref
Crossref
Tien-Tsai Cheng, Shan-Fu Yu, Fu-Mei Su, Yin-Chou Chen, Ben Yu-Jih Su, Wen-Chan Chiu, Chung-Yuan Hsu, Jia-Feng Chen, Chi-Hua Ko & Han-Ming Lai. (2018) Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Imad Ghozlani, Aziza Mounach, Mirieme Ghazi, Anass Kherrab, Radouane Niamane & Abdellah El Maghraoui. (2018) Influence of anti-cyclic citrullinated peptide on disease activity, structural severity, and bone loss in Moroccan women with rheumatoid arthritis. The Egyptian Rheumatologist 40:2, pages 73-78.
Crossref
Crossref
Rie Kodama, Shigeyuki Muraki, Toshiko Iidaka, Hiroyuki Oka, Masatoshi Teraguchi, Ryohei Kagotani, Yoshiki Asai, Hiroshi Hashizume, Munehito Yoshida, Hiroshi Kawaguchi, Kozo Nakamura, Toru Akune, Sakae Tanaka & Noriko Yoshimura. (2017) Serum levels of matrix metalloproteinase-3 and autoantibodies related to rheumatoid arthritis in the general Japanese population and their association with osteoporosis and osteoarthritis: the ROAD study. Journal of Bone and Mineral Metabolism 36:2, pages 246-253.
Crossref
Crossref
Cecilia Engdahl, Holger Bang, Katharina Dietel, Stefanie C Lang, Ulrike Harre & Georg Schett. (2017) Periarticular Bone Loss in Arthritis Is Induced by Autoantibodies Against Citrullinated Vimentin. Journal of Bone and Mineral Research 32:8, pages 1681-1691.
Crossref
Crossref
Ali I. Fouda, Ibrahim Rageh, Nashwa I. Hashaad & Sabreen Hamza. (2017) Synovial fluid anti-citrulline-containing peptide antibody and its role in the diagnosis of rheumatoid arthritis. Egyptian Rheumatology and Rehabilitation 44:3, pages 97-102.
Crossref
Crossref
Emilio Martin-Mola, Alejandro Balsa, Rosario García-Vicuna, Juan Gómez-Reino, Miguel Angel González-Gay, Raimon Sanmartí & Estíbaliz Loza. (2016) Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review. Rheumatology International 36:8, pages 1043-1063.
Crossref
Crossref
Piet Geusens, Steven R. Goldring, Karine Briot & Christian Roux. 2016. Osteoimmunology. Osteoimmunology
187
214
.
Wanruchada Katchamart, Ajchara Koolvisoot, Emvalee Aromdee, Praveena Chiowchanwesawakit & Chayawee Muengchan. (2015) Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Rheumatology International 35:10, pages 1693-1699.
Crossref
Crossref
Behzad Heidari, Alireza Firouzjahi, Maryam Haj Mirghssemi, Parham Heidari, Niloofar Hakimi & Karim Hajian-Tilaki. (2015) Relationship between bone mineral density and duration of rheumatoid arthritis. Indian Journal of Rheumatology 10:1, pages 10-15.
Crossref
Crossref
Arnd Kleyer & Georg Schett. (2014) Arthritis and bone loss. Current Opinion in Rheumatology 26:1, pages 80-84.
Crossref
Crossref
Roland Kocijan, Ulrike Harre & Georg Schett. (2013) ACPA and Bone Loss in Rheumatoid Arthritis. Current Rheumatology Reports 15:10.
Crossref
Crossref
Kumi Shidara, Eisuke Inoue, Daisuke Hoshi, Eri Sato, Ayako Nakajima, Shigeki Momohara, Atsuo Taniguchi & Hisashi Yamanaka. (2010) Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan. Rheumatology International 32:2, pages 361-366.
Crossref
Crossref
Piet Geusens & Willem F Lems. (2011) Osteoimmunology and osteoporosis. Arthritis Research & Therapy 13:5, pages 242.
Crossref
Crossref
Altan Ercan, Jing Cui, Dereck E. W. Chatterton, Kevin D. Deane, Melissa M. Hazen, William Brintnell, Colin I. O'Donnell, Lezlie A. Derber, Michael E. Weinblatt, Nancy A. Shadick, David A. Bell, Ewa Cairns, Daniel H. Solomon, V. Michael Holers, Pauline M. Rudd & David M. Lee. (2010) Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis & Rheumatism 62:8, pages 2239-2248.
Crossref
Crossref
R. Engelmann & B. Müller-Hilke. (2009) Antikörper gegen citrullinierte Peptidantigene in Klinik und ForschungAntibodies against citrullinated peptides in clinical practice and research. Zeitschrift für Rheumatologie 68:6, pages 485-490.
Crossref
Crossref